Prescribing for older people

BMJ

Volumn 336, Issue 7644, 2008, Pages 606-609

  Milton, James C ^a   Hill Smith, Ian ^b   Jackson, Stephen H D ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b Churchfield Medical Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CHLORPROPAMIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; TRICYCLIC ANTIDEPRESSANT AGENT;

AGING; ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; COST CONTROL; DRUG EFFECT; DRUG INDUSTRY; ELDERLY CARE; EVIDENCE BASED MEDICINE; FALLING; FRAIL ELDERLY; HEALTH EDUCATION; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; ORTHOSTATIC HYPOTENSION; PATHOLOGY; PHARMACODYNAMICS; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; URINARY PROBLEM; URINE RETENTION; XEROSTOMIA; AGED; CLINICAL COMPETENCE; CLINICAL PHARMACOLOGY; CLINICAL PRACTICE; DECISION MAKING; DRUG USE; EDUCATION; GENERAL PRACTICE; GERIATRICS; HEALTH SERVICE; MEDICAL EDUCATION; PHARMACOKINETICS; PHYSIOLOGY; STANDARD; STATISTICS;

AGED; AGING; CLINICAL COMPETENCE; DECISION MAKING; DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL, CONTINUING; FAMILY PRACTICE; GERIATRICS; HEALTH SERVICES MISUSE; HUMANS; PHARMACOKINETICS; PHARMACOLOGY, CLINICAL; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PRESCRIPTIONS, DRUG;

EID: 40949126493     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39503.424653.80     Document Type: Review

References (38)

1. Office for National Statistics. Key population and vital statistics. 2005. www.statistics.gov.uk/downloads/theme_population/ KPVS32_2005/KPVS2005.pdf.
2. Department of Health. Prescriptions dispensed in the community for 1993 to 2003. England: DH, 2004.
3. Mallet L, Spinewine A, Huang A. Prescribing in elderly people 2: the challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91.
4. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2003;57:6-14.
5. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systemic review of the role of the pharmacist. Drugs Aging 2003;20:817-32.
6. Information Centre (Health Care). Prescriptions dispensed in the community. Statistics for 1996 to 2006: England. 2007. www.ic.nhs.uk/ webfiles/publications/PrescDispensed%2096to06/ Bulletin%20220807%20version%20for%202006.pdf.
7. Campbell SE, Seymour DG, Primrose WR. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing 2004;33:110-5.
8. Frazier SC. Health outcomes and polypharmacy in elderly individuals. J Gerontol Nursing 2005;31:4-11.
9. Edwards RF, Harrison TM, Davis SM. Potentially inappropriate prescribing for geriatric inpatients: an acute care of the elderly unit compared to a general medicine service. Consult Pharmacist 2003;18:37-49.
10. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003;163:2716-24.
11. Mant J, Hobbs R, Fletcher K, Mant J, Hobbs FD, Fletcher K, et al; BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham atrial fibrillation treatment of the aged study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503.
12. The National Collaborating Centre for Chronic Conditions. Atrial fibrillation. National clinical guideline for management in primary and secondary care. London: Royal College of Physicians, 2006.
13. Mangoni AA, Jackson SHD. The implications of a growing evidence base for drug use in elderly patients. Part 2. ACE inhibitors and angiotensin receptor blockers in heart failure and high cardiovascular risk patients. Br J Clin Pharmacol 2006;61:502-12.
14. Mangoni AA, Jackson SHD. The implications of a growing evidence base for drug use in elderly patients. Part 3. β-adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarction. Br J Clin Pharmacol 2006;61:513-20.
15. Mangoni AA, Jackson SHD. The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention. Br J Clin Pharmaol 2006;61:494-501.
16. Dhesi JK, Allain TJ, Mangoni AA, Jackson SHD. The implications of a growing evidence base for drug use in elderly patients. Part 4. Vitamin D and bisphosphonates for fractures and osteoporosis. Br J Clin Pharmacol 2006;61:521-8.
17. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007;5:31-9.
18. Department of Health. Medicines and older people: implementing medicines-related aspects of the NSF for older people 2001. 2001 www.hcsu.org.uk/index.php?option=com_docman&task=doc_download&gid= 322%20.
19. Middlesborough Primary Care Trust. Guidance to support the production of a repeat prescribing protocol. www.npc.co.uk/repeat_prescribing/ Policy%203%20-%20Sue%20Prout.pdf.
20. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systemic review of the role of the pharmacist. Drugs Aging 2003;20:817-32.
21. Wu JYF, Leung WYS, Chang S, Lee B, Zee B, Tong PC, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006;333:522-7.
22. Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother 2007;41:861-8.
23. Blenkinsopp A, Celino G, Bond C, Inch J. Medicines use reviews: the first year of a new community pharmacy service. Pharm J 2007;278:218-23.
24. Bond C, Matheson C, Williams S, Williams P, Donnan P. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract 2000;50:271-5.
25. Duggan C, Feldman R, Hough J, Bates I. Reducing adverse prescribing discrepancies following hospital discharge. Int J Pharm Pract 1998;6:77-82.
26. Horrocks S, Anderson E, Salisbury C. Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. BMJ 2002;324:819-23.
27. O'Brien T, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000;(2):CD000409.
28. Freemantle N, Nazareth I, Eccles M, Wood J, Haines A; Evidence-based OutReach Trialists. A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. Br J Gen Pract 2002;52:290-5.
29. Batty GM, Oborne CA, Hooper R, Jackson SHD. Investigating intervention strategies to increase the appropriate use of benzodiazepines in elderly medical inpatients. Br J Clin Gov 2001;6:252-8.
30. National Health Service. ePrescribing. 2008. www. connectingforhealth.nhs.uk/systemsandservices/eprescribing.
31. Lapane KL, Dubé C, Schneider KL, Quilliam BJ. Patient perceptions regarding electronic prescriptions: is the geriatric patient ready? J Am Geriatr Soc 2007;55:1254-9.
32. Franklin BD, O'Grady K, Donyai P, Jacklin A, Barber N. The impact of a closed-loop electronic prescribing and administration system on prescribing errors, administration errors and staff time: a before-and-after study. Qual Safety Health Care 2007;16:279-84.
33. Franklin BD, O'Grady K, Donyai P, Jacklin A, Barber N. The impact of a closed-loop electronic prescribing and automated dispensing system on the ward pharmacist's time and activities. Int J Pharmacy Pract 2007;15:133-9.
34. Batty GM, Grant RL, Aggarwal R, Lowe D, Potter JM, Pearson MG, et al. National clinical sentinel audit of evidence-based prescribing for older people. J Eval Clin Pract 2004;10:273-9.
35. Oborne CA, Batty GM, Maskrey V, Swift CG, Jackson SHD. Development of prescribing indicators for elderly medical patients. Br J Clin Pharmacol 1997;43:91-7.
36. Oborne CA, Hooper R, Swift CG, Jackson SHD. Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 2003;32:102-8.
37. Batty GM, Grant RL, Aggarwal R, Lowe D, Potter JM, Pearson MG, et al. Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing 2003;32:292-8.
38. Swift CG. Prescribing in old age. BMJ 1988;296:913-5.